A recent study describes a role for hypoxic signaling in the small intestine in the etiology of nonalcoholic fatty liver disease (NAFLD) and suggests that HIF-2α inhibitors may be an effective option for the treatment of this disease.
References
Flegal, K.M., Kruszon-Moran, D., Carroll, M.D., Fryar, C.D. & Ogden, C.L. J. Am. Med. Assoc. 315, 2284–2291 (2016).
Younossi, Z. et al. Nat. Rev. Gasroenterol. Hepatol. http://dx.doi.org/10.1038/nrgastro.2017.109 (2017).
Xie, C. et al. Nat. Med. 23, 1298–1308 (2017).
Pagadala, M., Kasumov, T., McCullough, A.J., Zein, N.N. & Kirwan, J.P. Trends Endocrinol. Metab. 23, 365–371 (2012).
Rankin, E.B. et al. Mol. Cell. Biol. 29, 4527–4538 (2009).
Taniguchi, C.M. et al. Nat. Med. 19, 1325–1330 (2013).
Wei, K. et al. Nat. Med. 19, 1331–1337 (2013).
Ramakrishnan, S.K. et al. Cell Metab. 23, 505–516 (2016).
Hosogai, N. et al. Diabetes 56, 901–911 (2007).
Lee, K.Y., Gesta, S., Boucher, J., Wang, X.L. & Kahn, C.R. Cell Metab. 14, 491–503 (2011).
Martínez-Sáez, O., Gajate Borau, P., Alonso-Gordoa, T., Molina-Cerrillo, J. & Grande, E. Crit. Rev. Oncol. Hematol. 111, 117–123 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
LaGory, E., Giaccia, A. Long-range hypoxia signaling in NAFLD. Nat Med 23, 1251–1252 (2017). https://doi.org/10.1038/nm.4436
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4436
- Springer Nature America, Inc.